SCHEMBL10313883

SCHEMBL10313883

N#Cc1ccc(-n2cnc3c(NN)nc(-c4ccc(C(F)(F)F)cc4)nc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
ADORA3 P0DMS8 1/20 0.37
MAOB P27338 1/20 0.35
GGPS1 O95749 1/20 0.35
DGAT1 O75907 1/20 0.34
SOAT1 P35610 1/20 0.34
KCNH2 Q12809 1/20 0.34
CTSS P25774 2/20 0.34
CTSK P43235 2/20 0.34
CTSV O60911 1/20 0.34
CTSL P07711 1/20 0.34
CTSH P09668 1/20 0.34
CASP1 P29466 1/20 0.34
CTSC P53634 1/20 0.34
CTSZ Q9UBR2 1/20 0.34
KDM1A O60341 2/20 0.34
XDH P47989 1/20 0.34
VNN1 O95497 1/20 0.34
PDPK1 O15530 1/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275484 0.88 KIF11 (0.46) KIF11MAOBDGAT1SOAT1KCNH2
SCHEMBL10313812 0.78 XDH (0.42) KIF11MAOBGGPS1DGAT1SOAT1
SCHEMBL10313898 0.78 CTSV (0.39) KIF11CTSSCTSKCTSVCTSL
SCHEMBL10276071 0.75 EGFR (0.43) KIF11ADORA3CTSSCTSKCTSV
SCHEMBL10276398 0.74 XDH (0.47) KIF11DGAT1SOAT1KCNH2XDH
SCHEMBL10313629 0.71 PI4KA (0.41) ADORA3XDHADORA2A
SCHEMBL12825950 0.69 KIF11 (0.44) KIF11CTSSCTSKKDM1A
SCHEMBL10276387 0.68 XDH (0.53) KIF11MAOBDGAT1SOAT1KCNH2
SCHEMBL10275865 0.67 KIF11 (0.36) KIF11DGAT1SOAT1KCNH2XDH
SCHEMBL10276444 0.66 KIF11 (0.36) KIF11MAOBCTSSCTSKCTSV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 KIF11 4069/4885ADORA3 3/4885MAOB 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.